Solventum Corporation SOLV

NYSE · Healthcare · Medical - Instruments & Supplies

$84.50

Close on Fri, 20 Nov 2026 · market value $14.4B

No single growth bet

Solventum Corporation is valued on the income it pays out or on its book, not on one rate of revenue growth, so its price doesn't reduce to a single bet. The three stories below still show what it could be worth.

Both sides

Three stories, three values

Bear

$2.86

Base

$2.89

Bull

$2.92

Today $85

  • Bear $2.86. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $2.89. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $2.92. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

At a glance

Healthcare · Medical - Instruments & Supplies · listed on NYSE

Revenue, FY2025
$8.3B
Growth, 3 years a year
−0.2%
Cash margin
−0.1%
Net debt
$4.2B
Shares, 3-year change
+1.6%
Dividend yield
0%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.